Straumann (OTCMKTS:SAUHY) Shares Down 5.3% – Time to Sell?

Straumann Holding AG (OTCMKTS:SAUHY) shares were down 5.3% during trading on Wednesday. The company traded as low as $10.96 and last traded at $10.96. Approximately 309 shares traded hands during trading, a decline of 100% from the average session volume of 123,718 shares. The stock had previously closed at $11.57.

Analyst Upgrades and Downgrades

SAUHY has been the topic of a number of analyst reports. Berenberg Bank raised Straumann to a “strong-buy” rating in a research note on Thursday, September 17th. Barclays reaffirmed an “overweight” rating on shares of Straumann in a research note on Thursday, June 18th. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th. UBS Group raised Straumann from a “neutral” rating to a “buy” rating in a research note on Tuesday, September 1st. Finally, The Goldman Sachs Group upgraded Straumann from a “neutral” rating to a “buy” rating in a report on Monday, September 14th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Straumann Stock Down 1.1%

The company’s 50 day simple moving average is $11.91 and its 200 day simple moving average is $11.63.

Straumann Company Profile

Straumann Group is a Swiss company focused on implant, restorative and orthodontic dentistry. The company develops, manufactures and distributes dental implants, prosthetic components, instruments and related solutions used by dental professionals and laboratories.

Its portfolio also includes biomaterials for tissue regeneration, digital dentistry technologies and intraoral scanning solutions, as well as clear aligners offered through its ClearCorrect business. Straumann provides products and services intended to support dental restoration, tooth replacement, orthodontic treatment and digital treatment planning.

Founded in 1954 and headquartered in Basel, Switzerland, Straumann serves dental professionals, laboratories and patients through operations and distribution networks across numerous markets worldwide.